Plasmodium vivax malaria serological exposure markers: Assessing the degree and implications of cross-reactivity with P. knowlesi

dc.contributor.authorLongley R.J.
dc.contributor.authorGrigg M.J.
dc.contributor.authorSchoffer K.
dc.contributor.authorObadia T.
dc.contributor.authorHyslop S.
dc.contributor.authorPiera K.A.
dc.contributor.authorNekkab N.
dc.contributor.authorMazhari R.
dc.contributor.authorTakashima E.
dc.contributor.authorTsuboi T.
dc.contributor.authorHarbers M.
dc.contributor.authorTetteh K.
dc.contributor.authorDrakeley C.
dc.contributor.authorChitnis C.E.
dc.contributor.authorHealer J.
dc.contributor.authorTham W.H.
dc.contributor.authorSattabongkot J.
dc.contributor.authorWhite M.T.
dc.contributor.authorCooper D.J.
dc.contributor.authorRajahram G.S.
dc.contributor.authorBarber B.E.
dc.contributor.authorWilliam T.
dc.contributor.authorAnstey N.M.
dc.contributor.authorMueller I.
dc.contributor.otherMahidol University
dc.date.accessioned2023-06-18T16:46:45Z
dc.date.available2023-06-18T16:46:45Z
dc.date.issued2022-06-21
dc.description.abstractSerological markers are a promising tool for surveillance and targeted interventions for Plasmodium vivax malaria. P. vivax is closely related to the zoonotic parasite P. knowlesi, which also infects humans. P. vivax and P. knowlesi are co-endemic across much of South East Asia, making it important to design serological markers that minimize cross-reactivity in this region. To determine the degree of IgG cross-reactivity against a panel of P. vivax serological markers, we assayed samples from human patients with P. knowlesi malaria. IgG antibody reactivity is high against P. vivax proteins with high sequence identity with their P. knowlesi ortholog. IgG reactivity peaks at 7 days post-P. knowlesi infection and is short-lived, with minimal responses 1 year post-infection. We designed a panel of eight P. vivax proteins with low levels of cross-reactivity with P. knowlesi. This panel can accurately classify recent P. vivax infections while reducing misclassification of recent P. knowlesi infections.
dc.identifier.citationCell Reports Medicine Vol.3 No.6 (2022)
dc.identifier.doi10.1016/j.xcrm.2022.100662
dc.identifier.eissn26663791
dc.identifier.pmid35732155
dc.identifier.scopus2-s2.0-85132610519
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/83694
dc.rights.holderSCOPUS
dc.subjectBiochemistry, Genetics and Molecular Biology
dc.titlePlasmodium vivax malaria serological exposure markers: Assessing the degree and implications of cross-reactivity with P. knowlesi
dc.typeArticle
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85132610519&origin=inward
oaire.citation.issue6
oaire.citation.titleCell Reports Medicine
oaire.citation.volume3
oairecerif.author.affiliationRIKEN Center for Integrative Medical Sciences
oairecerif.author.affiliationFaculty of Tropical Medicine, Mahidol University
oairecerif.author.affiliationUniversité Paris Cité
oairecerif.author.affiliationDepartment of Medicine
oairecerif.author.affiliationLondon School of Hygiene & Tropical Medicine
oairecerif.author.affiliationWalter and Eliza Hall Institute of Medical Research
oairecerif.author.affiliationUniversity of Melbourne
oairecerif.author.affiliationMenzies School of Health Research
oairecerif.author.affiliationEhime University
oairecerif.author.affiliationInstitut Pasteur, Paris
oairecerif.author.affiliationLtd.
oairecerif.author.affiliationGleneagles Hospital
oairecerif.author.affiliationINFECTIOUS DISEASE SOCIETY KOTA KINABALU
oairecerif.author.affiliationHospital Queen Elizabeth II

Files

Collections